REGULATION OF NATIONAL GENOMIC DATABASE GOVERNANCE IN JAPAN

1. INTRODUCTION

National genomic database governance in Japan concerns the collection, storage, processing, protection, sharing and secondary use of human genetic information for medical research, disease prevention, precision medicine and biotechnology development. Genomic databases contain highly sensitive information because genetic characteristics may reveal hereditary conditions, familial relationships and potential health risks.

Japan does not rely on one comprehensive statute exclusively governing all national genomic databases. Instead, governance operates through a combination of the Act on the Protection of Personal Information (APPI), the Next Generation Medical Infrastructure Act, the Act on the Promotion of Genomic Medicine, relevant ethical guidelines and institutional data-security requirements.

2. LEGAL AND REGULATORY FRAMEWORK

A. ACT ON THE PROTECTION OF PERSONAL INFORMATION (APPI)

The APPI establishes the principal framework for protecting personal information, including identifiable genetic and genomic information. It regulates collection, processing, disclosure, retention and third-party provision.

Key requirements include:

Appropriate specification of processing purposes.

Lawful acquisition and management of personal information.

Security measures against unauthorized access and disclosure.

Appropriate supervision of employees and contractors.

Compliance with third-party provision requirements.

Additional safeguards for transfers of personal data outside Japan.

Genetic information must be protected according to its identifiability and sensitivity. Removing names does not automatically make genomic information anonymous because genetic sequences may permit re-identification.

B. NEXT GENERATION MEDICAL INFRASTRUCTURE ACT

This legislation facilitates the collection and utilization of medical information for research and medical innovation through certified business operators.

It establishes safeguards concerning medical information processing, certification, security and appropriate utilization. Its framework is particularly relevant where genomic information is linked with clinical records.

C. ACT ON THE PROMOTION OF GENOMIC MEDICINE

Japan's genomic medicine policy and statutory framework support the development of genomic medicine infrastructure, coordination among medical institutions and responsible utilization of genomic information. National genomic databases must operate consistently with applicable statutory requirements and government implementation measures.

3. GOVERNANCE OF NATIONAL GENOMIC DATABASES

Important governance responsibilities include:

Data collection: Institutions must establish appropriate legal grounds, explain research purposes and obtain consent where required.

Data classification: Identifiable, pseudonymized and anonymized genomic information must be distinguished.

Access management: Access should be restricted to authorized researchers and institutions.

Data sharing: Research collaboration must comply with applicable consent, disclosure and contractual requirements.

Cybersecurity: Encryption, authentication, access logs and incident-response procedures should protect genomic information.

International transfers: Overseas sharing must satisfy APPI requirements and applicable research-governance conditions.

Retention and deletion: Institutions must establish appropriate retention periods and procedures for disposing of information when its use is no longer justified.4. IMPORTANT JUDICIAL PRECEDENTS AND CASE LAWS

Japanese courts have not established a substantial body of reported judgments specifically concerning national genomic databases. However, privacy, medical confidentiality and database-security judgments provide analogous judicial authority.

1. WASEDA UNIVERSITY PERSONAL INFORMATION CASE – SUPREME COURT (12 SEPTEMBER 2003)

The Supreme Court held that students' personal information supplied to a university was legally protected even though it consisted of ordinary identifying details. Disclosure to police without obtaining consent constituted a violation of privacy in the circumstances.

Relevance: Directly analogous to unauthorized disclosure of genomic database records and the requirement to respect reasonable expectations of confidentiality.

2. WASEDA UNIVERSITY STUDENT INFORMATION CASE – TOKYO DISTRICT COURT (11 APRIL 2001)

The dispute concerned the university's disclosure of students' identifying information to police without consent. The District Court rejected the claims in that particular proceeding.

Relevance: Demonstrates the earlier judicial disagreement concerning privacy expectations and institutional disclosure. The subsequent Supreme Court ruling provides the stronger authority on the relevant privacy principle.

3. YAHOO! BB PERSONAL INFORMATION LEAK CASE – OSAKA DISTRICT COURT (19 MAY 2006)

The court imposed liability on the database-operating company after inadequate security controls permitted unauthorized access to customer information. It awarded compensation of ¥6,000 per claimant.

Relevance: Establishes an important analogous principle that database administrators must maintain adequate access controls and prevent foreseeable unauthorized disclosure.

4. YAHOO! BB DATA LEAK CASE – OSAKA HIGH COURT (2007)

The appellate proceedings addressed responsibility for the extensive customer-data leak and the supervisory obligations of the companies involved. Compensation was fixed at ¥5,500 per claimant, and the outcome became final following the Supreme Court's rejection of the further appeal.

Relevance: Supports institutional accountability and appropriate supervision of entities handling large-scale personal databases.

5. YAHOO! BB FINAL APPEAL – SUPREME COURT (14 DECEMBER 2007)

The Supreme Court rejected the appeal, allowing the compensation outcome to become final.

Relevance: Provides additional support for the importance of effective organizational security and accountability in large-scale information management.

6. TBC BEAUTY SALON PERSONAL INFORMATION LEAK CASE – TOKYO DISTRICT COURT (8 FEBRUARY 2007)

The litigation concerned the exposure of customer information through an improperly configured web server. The disclosed material included personal details and sensitive questionnaire information. Compensation was awarded to affected claimants.

Relevance: Analogous authority for preventing unauthorized internet exposure of sensitive medical, biological and genomic research records.

5. REGULATORY COMPLIANCE AND INSTITUTIONAL RESPONSIBILITIES

Organizations managing genomic databases should implement:

Independent ethical review before collecting or using human genomic samples.

Clear informed-consent procedures covering future research and data sharing.

Pseudonymization and separation of identifying information.

Role-based access controls and periodic security audits.

Documented data-sharing agreements between research institutions.

Breach notification and incident-response procedures.

Appropriate safeguards for international transfers.

Transparent procedures for withdrawal of consent, where applicable.

6. PRACTICAL LEGAL CHALLENGES

Major challenges include genetic re-identification, unauthorized commercial exploitation, cross-border research transfers, insufficient consent for secondary research and discrimination based on inherited genetic characteristics.

Another difficulty is balancing scientific innovation against individual privacy. Japan's genomic medicine legislation recognizes both the importance of developing genomic infrastructure and the necessity of protecting human dignity, personal rights and freedom from genetic discrimination.

7. CONCLUSION

National genomic database governance in Japan is based on coordinated statutory regulation, ethical oversight, privacy protection and institutional accountability. The Genomic Medicine Promotion Act, APPI and related medical-information legislation provide the principal legal foundations.

Although the cited judicial decisions are not direct genomic-database judgments, they establish important analogous principles concerning confidentiality, unauthorized disclosure, database security and organizational responsibility. Consequently, Japanese genomic database operators must combine scientific accessibility with robust privacy protection, informed consent, cybersecurity and transparent governance.